{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:04:11Z","timestamp":1791223451658,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2013,8,29]],"date-time":"2013-08-29T00:00:00Z","timestamp":1377734400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-013-1146-8","type":"journal-article","created":{"date-parts":[[2013,8,28]],"date-time":"2013-08-28T10:28:47Z","timestamp":1377685727000},"source":"Crossref","is-referenced-by-count":8,"title":["Nomograms to predict late urinary toxicity after prostate cancer radiotherapy"],"prefix":"10.1007","author":[{"given":"Romain","family":"Mathieu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan David Ospina","family":"Arango","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Beckendorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Bernard","family":"Delobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha","family":"Messai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciprian","family":"Chira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Bossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Le Pris\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Guerif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Dubray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-L\u00e9on","family":"Lagrange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Pommier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khemara","family":"Gnep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"De Crevoisier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,29]]},"reference":[{"key":"1146_CR1","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jama.280.11.969","volume":"280","author":"AV D\u2019Amico","year":"1998","unstructured":"D\u2019Amico AV, Whittington R, Malkowicz SB et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280:969","journal-title":"JAMA"},{"key":"1146_CR2","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.ijrobp.2004.07.723","volume":"61","author":"R Cheung","year":"2005","unstructured":"Cheung R, Tucker SL, Lee AK et al (2005) Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys 61:993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1146_CR3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.radonc.2009.08.004","volume":"93","author":"C Fiorino","year":"2009","unstructured":"Fiorino C, Valdagni R, Rancati T et al (2009) Dose-volume effects for normal tissues in external radiotherapy: pelvis. Radiother Oncol 93:153","journal-title":"Radiother Oncol"},{"key":"1146_CR4","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.eururo.2011.09.027","volume":"61","author":"L Budaus","year":"2012","unstructured":"Budaus L, Bolla M, Bossi A et al (2012) Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature. Eur Urol 61:112","journal-title":"Eur Urol"},{"key":"1146_CR5","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.ijrobp.2011.03.028","volume":"82","author":"R Valdagni","year":"2012","unstructured":"Valdagni R, Kattan MW, Rancati T et al (2012) Is it time to tailor the prediction of radio-induced toxicity in prostate cancer patients? Building the first set of nomograms for late rectal syndrome. Int J Radiat Oncol Biol Phys 82:1957","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1146_CR6","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1002\/cncr.24356","volume":"115","author":"R Valdagni","year":"2009","unstructured":"Valdagni R, Rancati T, Fiorino C (2009) Predictive models of toxicity with external radiotherapy for prostate cancer: clinical issues. Cancer 115:3141","journal-title":"Cancer"},{"key":"1146_CR7","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ijrobp.2010.03.049","volume":"80","author":"V Beckendorf","year":"2011","unstructured":"Beckendorf V, Guerif S, Le Prise E et al (2011) 70\u00a0Gy versus 80\u00a0Gy in localized prostate cancer: 5-year results of GETUG 06 randomized trial. Int J Radiat Oncol Biol Phys 80:1056","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1146_CR8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ijrobp.2009.07.242","volume":"75","author":"R Crevoisier de","year":"2009","unstructured":"de Crevoisier R, Pommier P, Bachaud J et al (2009) Image-guided radiation therapy (IGRT) in prostate cancer: preliminary results in prostate registration and acute toxicity of a randomized study. Int J Radiat Oncol Biol Phys 75:99","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1146_CR9","unstructured":"Beahrs OH (1992) American Joint Committee on cancer: manual for staging of cancer, 4th edn. JB Lippincott, Philadelphia, PA"},{"key":"1146_CR10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0022-5347(05)65395-5","volume":"167","author":"BG Gardner","year":"2002","unstructured":"Gardner BG, Zietman AL, Shipley WU et al (2002) Late normal tissue sequelae in the second decade after high dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer. J Urol 167:123","journal-title":"J Urol"},{"key":"1146_CR11","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0360-3016(98)00460-X","volume":"43","author":"DM Herold","year":"1999","unstructured":"Herold DM, Hanlon AL, Hanks GE (1999) Diabetes mellitus: a predictor for late radiation morbidity. Int J Radiat Oncol Biol Phys 43:475","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1146_CR12","first-page":"1831","volume":"29","author":"K Takeda","year":"2009","unstructured":"Takeda K, Ogawa Y, Ariga H et al (2009) Clinical correlations between treatment with anticoagulants\/antiaggregants and late rectal toxicity after radiotherapy for prostate cancer. Anticancer Res 29:1831","journal-title":"Anticancer Res"},{"key":"1146_CR13","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.ijrobp.2009.02.026","volume":"76","author":"KS Choe","year":"2010","unstructured":"Choe KS, Jani AB, Liauw SL (2010) External beam radiotherapy for prostate cancer patients on anticoagulation therapy: how significant is the bleeding toxicity? Int J Radiat Oncol Biol Phys 76:755","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1146_CR14","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.juro.2010.04.069","volume":"184","author":"G Novara","year":"2010","unstructured":"Novara G, Ficarra V, D\u2019Elia C et al (2010) Evaluating urinary continence and preoperative predictors of urinary continence after robot assisted laparoscopic radical prostatectomy. J Urol 184:1028","journal-title":"J Urol"},{"key":"1146_CR15","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.juro.2009.11.033","volume":"183","author":"D Teber","year":"2010","unstructured":"Teber D, Sofikerim M, Ates M et al (2010) Is type 2 diabetes mellitus a predictive factor for incontinence after laparoscopic radical prostatectomy? A matched pair and multivariate analysis. J Urol 183:1087","journal-title":"J Urol"},{"key":"1146_CR16","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/S0360-3016(02)02829-8","volume":"53","author":"A Pollack","year":"2002","unstructured":"Pollack A, Zagars GK, Starkschall G et al (2002) Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial. Int J Radiat Oncol Biol Phys 53:1097","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1146_CR17","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/jama.294.10.1233","volume":"294","author":"AL Zietman","year":"2005","unstructured":"Zietman AL, DeSilvio ML, Slater JD et al (2005) Comparison of conventional-dose vs high-dose conformal radiation therapy in clinically localized adenocarcinoma of the prostate: a randomized controlled trial. JAMA 294:1233","journal-title":"JAMA"},{"key":"1146_CR18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S1470-2045(07)70143-2","volume":"8","author":"DP Dearnaley","year":"2007","unstructured":"Dearnaley DP, Sydes MR, Graham JD et al (2007) Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. Lancet Oncol 8:475","journal-title":"Lancet Oncol"},{"key":"1146_CR19","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.ijrobp.2008.02.073","volume":"72","author":"A Al-Mamgani","year":"2008","unstructured":"Al-Mamgani A, van Putten WL, Heemsbergen WD et al (2008) Update of Dutch multicenter dose-escalation trial of radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 72:980","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1146_CR20","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.ijrobp.2007.11.044","volume":"70","author":"MJ Zelefsky","year":"2008","unstructured":"Zelefsky MJ, Levin EJ, Hunt M et al (2008) Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 70:1124","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1146_CR21","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.ijrobp.2008.10.087","volume":"74","author":"F Leborgne","year":"2009","unstructured":"Leborgne F, Fowler J (2009) Late outcomes following hypofractionated conformal radiotherapy vs. standard fractionation for localized prostate cancer: a nonrandomized contemporary comparison. Int J Radiat Oncol Biol Phys 74:1441","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1146_CR22","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/jjco\/hyp086","volume":"39","author":"S Namiki","year":"2009","unstructured":"Namiki S, Ishidoya S, Ito A et al (2009) Five-year follow-up of health-related quality of life after intensity-modulated radiation therapy for prostate cancer. Jpn J Clin Oncol 39:732","journal-title":"Jpn J Clin Oncol"},{"key":"1146_CR23","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/cncr.25467","volume":"117","author":"ZA Alicikus","year":"2011","unstructured":"Alicikus ZA, Yamada Y, Zhang Z et al (2011) Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer. Cancer 117:1429","journal-title":"Cancer"},{"key":"1146_CR24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0360-3016(94)00599-G","volume":"32","author":"K Wallner","year":"1995","unstructured":"Wallner K, Roy J, Harrison L (1995) Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Int J Radiat Oncol Biol Phys 32:465","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1146_CR25","doi-asserted-by":"crossref","unstructured":"Zelefsky MJ, Kollmeier M, Cox B et al (2012) Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer. Int J Radiat Oncol Biol Phys (in press)","DOI":"10.1016\/j.ijrobp.2011.11.047"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-013-1146-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00345-013-1146-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-013-1146-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T09:40:10Z","timestamp":1559036410000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00345-013-1146-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,29]]},"references-count":25,"alternative-id":["1146"],"URL":"https:\/\/doi.org\/10.1007\/s00345-013-1146-8","relation":{},"ISSN":["0724-4983","1433-8726"],"issn-type":[{"value":"0724-4983","type":"print"},{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,29]]}}}